Generic Ozempic, Wegovy Coming to B.C. Soon
Health Canada reviews nine generic semaglutide submissions. Cheaper versions of Ozempic and Wegovy could soon improve access for diabetes and weight loss patients in British Columbia.
Health Canada reviews nine generic semaglutide submissions. Cheaper versions of Ozempic and Wegovy could soon improve access for diabetes and weight loss patients in British Columbia.
New research shows patients quickly regain weight after ending GLP-1 medications like Wegovy. Experts stress the need for long-term lifestyle strategies. Learn the findings.
Novo Nordisk launches Wegovy pill in the U.S., providing a flexible, needle-free option for weight management. Learn about this new alternative to injectable medications.
Shares of Novo Nordisk surged nearly 8% after the U.S. FDA approved its Wegovy weight-loss pill. The landmark decision marks a major expansion for the obesity drug market.
U.S. regulators have approved the Wegovy pill for weight loss, a major development in pharmaceutical treatment. Learn about the details and potential impact of this new drug.
New research reveals how diabetes medications Ozempic and Wegovy are transforming Canadian shopping patterns and food consumption. Discover the surprising impacts.
Novo Nordisk introduces $349 cash price for Wegovy weight-loss drug ahead of schedule. Learn how this affects Canadian healthcare access and affordability.
Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.